Key result
Mexiletine matches lignocaine for treating post-surgical ventricular arrhythmias but offers a slight crossover advantage.
Why the study?
Does mexiletine improve control of the rhythm compared to lignocaine in patients with ventricular arrhythmias after open-heart surgery?
RCT (n=30)
Open-label
randomly allocated
Does mexiletine improve control of the rhythm compared to lignocaine in patients with ventricular arrhythmias after open-heart surgery?
Mexiletine and lignocaine show comparable efficacy for treating ventricular arrhythmias after open-heart surgery.
Answers are grounded in this paper and cite their sources.
Mexiletine offers a comparable alternative to lignocaine for post-surgical ventricular arrhythmias; confirms equivalence in this RCT.
We made an open comparison of lignocaine and mexiletine in the treatment of ventricular arrhythmias occurring after open-heart surgery. Thirty patients whose arrhythmia did not respond to correction of metabolic disturbances were randomly allocated to receive treatment either with lignocaine or with mexiletine in fixed dosage schedules (15 in each group). Failure to control the rhythm or recurrent abnormality led to administration of a further dose and, if this was unsuccessful, to crossover to the alternative agent. The two drugs were comparable in efficacy, but mexiletine was slightly more effective when administered after lignocaine than the converse.
No takes yet. Share an insight, caveat, or question.
Bury et al. (1982) conducted an RCT in Ventricular arrhythmias after open-heart surgery (n=30). Mexiletine vs. Lignocaine was evaluated on Efficacy in controlling the rhythm or recurrent abnormality. Mexiletine and lignocaine demonstrated comparable efficacy in treating ventricular arrhythmias after open-heart surgery, with mexiletine being slightly more effective as a crossover agent.
Synapse has enriched 10 related papers. Consider them for comparative context: